Combined effects of psychostimulants and morphine on locomotor activity in mice
- PMID: 15599100
- DOI: 10.1254/jphs.fpj04039x
Combined effects of psychostimulants and morphine on locomotor activity in mice
Abstract
Simultaneous administration of psychostimulants and opioids is a major drug abuse problem worldwide. This combination appears to produce synergistic effects on behavior at low doses; however, there is little direct evidence that the combination is stronger than either drug alone. Therefore, we investigated interactions between psychostimulants and morphine on locomotor activity in mice. Low doses of cocaine (5.0 mg/kg) or methamphetamine (0.5 mg/kg) and morphine (10 mg/kg) enhance locomotor activity in a synergistic fashion. Effective doses of cocaine (20 mg/kg) and morphine (20 mg/kg) increased locomotion in an additive fashion. In contrast, combination of methamphetamine (1.0 and 2.0 mg/kg) and morphine (10 and 20 mg/kg) did not merely enhance their effects (or attenuated the peak effects of methamphetamine-induced hyperlocomotion). These results indicate that different mechanisms explain the interaction between morphine and methamphetamine or cocaine. It is well known that psychostimulants- and opioids-induced hyperlocomotion is mediated by the activation of the dopaminergic system, however, haloperidol (a dopamine receptor antagonist) and U50,488H (which attenuates dopamine release from nerve terminals) significantly increased the effects of methamphetamine and morphine on the locomotor activity. These results suggest that excess dopaminergic activation may be involved in the effects of methamphetamine and morphine on locomotor activity in mice.
Similar articles
-
Complicated interaction between psychostimulants and morphine in expression of phenotype of behavior in the dopaminergic system of BALB/c mice.J Pharmacol Sci. 2007 Dec;105(4):326-33. doi: 10.1254/jphs.fp0070653. Epub 2007 Dec 1. J Pharmacol Sci. 2007. PMID: 18057777
-
Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice.Eur J Pharmacol. 2006 Feb 17;532(1-2):81-7. doi: 10.1016/j.ejphar.2005.12.035. Epub 2006 Feb 7. Eur J Pharmacol. 2006. PMID: 16464448
-
Effects of spiradoline mesylate, a selective kappa-opioid-receptor agonist, on the central dopamine system with relation to mouse locomotor activity and analgesia.Jpn J Pharmacol. 1993 Jul;62(3):223-30. doi: 10.1254/jjp.62.223. Jpn J Pharmacol. 1993. PMID: 8411771
-
Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions.Ann N Y Acad Sci. 2001 Jun;937:93-120. doi: 10.1111/j.1749-6632.2001.tb03560.x. Ann N Y Acad Sci. 2001. PMID: 11458542 Review.
-
[Underlying Mechanisms of Methamphetamine-Induced Self-Injurious Behavior and Lethal Effects in Mice].Nihon Eiseigaku Zasshi. 2018;73(1):51-56. doi: 10.1265/jjh.73.51. Nihon Eiseigaku Zasshi. 2018. PMID: 29386447 Review. Japanese.
Cited by
-
Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction.J Neuroimmune Pharmacol. 2011 Dec;6(4):503-15. doi: 10.1007/s11481-011-9297-0. Epub 2011 Jul 16. J Neuroimmune Pharmacol. 2011. PMID: 21766222 Free PMC article. Review.
-
Automated home-cage for the evaluation of innate non-reflexive pain behaviors in a mouse model of inflammatory pain.Sci Rep. 2021 Jun 10;11(1):12240. doi: 10.1038/s41598-021-91444-4. Sci Rep. 2021. PMID: 34112846 Free PMC article.
-
Interactions Between Opioids and Dextroamphetamine on Locomotor Activity: Influence of an Opioid's Relative Efficacy at the Mu Receptor.Front Psychiatry. 2022 Jan 5;12:790471. doi: 10.3389/fpsyt.2021.790471. eCollection 2021. Front Psychiatry. 2022. PMID: 35069292 Free PMC article.
-
Genetically correlated effects of selective breeding for high and low methamphetamine consumption.Genes Brain Behav. 2009 Nov;8(8):758-71. doi: 10.1111/j.1601-183X.2009.00522.x. Epub 2009 Jul 21. Genes Brain Behav. 2009. PMID: 19689456 Free PMC article.
-
Visualization of the existence of LEAP2 in the nucleus accumbens and its role in amphetamine-induced locomotor activity.Mol Brain. 2025 Jul 3;18(1):57. doi: 10.1186/s13041-025-01227-5. Mol Brain. 2025. PMID: 40611288 Free PMC article.